Clinical trial
Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar…
NCT00107731 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00107731 |
|---|---|
| Title | Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder |
| Official title | A Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo When Used as Adjunct to Mood Stabilizers (Lithium or Valproate) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated) |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar I Disorder |
| Intervention type | Drug |
| Interventions | quetiapine fumarate, lithium, divalproex |
| Enrollment | 710 |
| Start date | Apr 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Apr 8, 2005 |
| Last update posted | Mar 25, 2009 |
| Countries | Australia, Belgium, Bulgaria, Czechia, Finland, France, Germany, Hungary, Italy, Norway, Poland, Russia and 6 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: